Modality.AI, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Modality.AI, Inc. - overview
Established
2018
Location
San Francisco, CA, US
Primary Industry
Healthcare
About
Based in California, US, and founded in 2018, Modality. AI, Inc. provides a multimodal system to assess neurological and psychiatric states, both in the clinic and remotely. David Pautler (CTO) and David Suendermann-Oeft (CEO) are the co-founders of the company.
In August 2021, Modality. AI, Inc. raised USD 2. 1 million in seed funding from Relentless Pursuit Partners and Novalis Biotech.
The company provides an automated, clinically validated, multimodal system to assess neurological and psychiatric states both in-person and remotely, allowing researchers and clinicians to analyse data in near real-time and track treatment response over time. The clinic treats a wide range of conditions, including ALS, Parkinson's disease, depression, schizophrenia, autism, multiple sclerosis, Lyme disease, chronic pain, and others. Modality. AI’s partners include the University of California San Francisco, Manhattan Psychiatric Center, NYU Langone Health, Everything ALS, and others.
The organization plans to use the August 2021 funding to accelerate its commercial pipeline and expedite FDA approval for use in clinical care.
Current Investors
Relentless Pursuit Partners, Novalis Biotech
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Medical Software, Analytics & Performance Software
Website
www.modality.ai
Verticals
Artificial Intelligence
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Modality.AI, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.